Asmaa Nabil-Adam

538 total citations
26 papers, 367 citations indexed

About

Asmaa Nabil-Adam is a scholar working on Aquatic Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Asmaa Nabil-Adam has authored 26 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Aquatic Science, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Asmaa Nabil-Adam's work include Seaweed-derived Bioactive Compounds (7 papers), Marine Sponges and Natural Products (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Asmaa Nabil-Adam is often cited by papers focused on Seaweed-derived Bioactive Compounds (7 papers), Marine Sponges and Natural Products (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Asmaa Nabil-Adam collaborates with scholars based in Egypt, Australia and Netherlands. Asmaa Nabil-Adam's co-authors include Mohamed A. Shreadah, Tamer El-Sayed Ali, Mohamed L. Ashour, Tamer M. Tamer, Mohamed A. Hassan, Ahmed M. Abdel-Azeem, Doaa A. Ghareeb, Nicole J. de Voogd, E. Lederer and El Sayed H. El Ashry and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Asmaa Nabil-Adam

26 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asmaa Nabil-Adam Egypt 13 112 89 73 60 54 26 367
Cynthia Layse Ferreira de Almeida Brazil 7 132 1.2× 67 0.8× 22 0.3× 21 0.3× 33 0.6× 8 368
Iman A. M. Abdel-Rahman Egypt 11 165 1.5× 106 1.2× 22 0.3× 28 0.5× 40 0.7× 28 438
Adila Aipire China 15 65 0.6× 161 1.8× 93 1.3× 77 1.3× 19 0.4× 32 424
Yosie Andriani Malaysia 10 37 0.3× 75 0.8× 37 0.5× 24 0.4× 52 1.0× 42 331
Zahra Rastian Iran 8 121 1.1× 92 1.0× 28 0.4× 19 0.3× 40 0.7× 11 398
Saba Beigh Saudi Arabia 8 40 0.4× 81 0.9× 13 0.2× 34 0.6× 37 0.7× 24 371
Yu-Fei Yao China 9 41 0.4× 112 1.3× 46 0.6× 73 1.2× 13 0.2× 15 361
P Arumugam India 12 99 0.9× 124 1.4× 14 0.2× 30 0.5× 38 0.7× 40 485
Liming Jin China 9 45 0.4× 196 2.2× 14 0.2× 87 1.4× 99 1.8× 26 423
Syarul Nataqain Baharum Malaysia 10 35 0.3× 101 1.1× 44 0.6× 31 0.5× 11 0.2× 31 372

Countries citing papers authored by Asmaa Nabil-Adam

Since Specialization
Citations

This map shows the geographic impact of Asmaa Nabil-Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa Nabil-Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa Nabil-Adam more than expected).

Fields of papers citing papers by Asmaa Nabil-Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asmaa Nabil-Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa Nabil-Adam. The network helps show where Asmaa Nabil-Adam may publish in the future.

Co-authorship network of co-authors of Asmaa Nabil-Adam

This figure shows the co-authorship network connecting the top 25 collaborators of Asmaa Nabil-Adam. A scholar is included among the top collaborators of Asmaa Nabil-Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asmaa Nabil-Adam. Asmaa Nabil-Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shreadah, Mohamed A., et al.. (2024). New vaccination approach using formalin-killed Streptococcus pyogenes vaccine on the liver of Oreochromis niloticus fingerlings. Scientific Reports. 14(1). 18341–18341. 4 indexed citations
3.
Nabil-Adam, Asmaa, Mohamed L. Ashour, Tamer M. Tamer, Mohamed A. Shreadah, & Mohamed A. Hassan. (2023). Interaction of Jania rubens Polyphenolic Extract as an Antidiabetic Agent with α-Amylase, Lipase, and Trypsin: In Vitro Evaluations and In Silico Studies. Catalysts. 13(2). 443–443. 29 indexed citations
4.
Nabil-Adam, Asmaa, Fadia S. Youssef, Mohamed L. Ashour, & Mohamed A. Shreadah. (2023). Neuroprotective and nephroprotective effects of Ircinia sponge in polycyclic aromatic hydrocarbons (PAHs) induced toxicity in animal model: a pharmacological and computational approach. Environmental Science and Pollution Research. 30(34). 82162–82177. 2 indexed citations
5.
Nabil-Adam, Asmaa, Mohamed L. Ashour, & Mohamed A. Shreadah. (2023). The hepatoprotective candidates by synergistic formula of marine and terrestrial against Acetaminophen toxicity using in-vitro, in-vivo, and in silico screening approach. Saudi Journal of Biological Sciences. 30(4). 103607–103607. 3 indexed citations
6.
Shreadah, Mohamed A., et al.. (2023). Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds. International Immunopharmacology. 126. 111072–111072. 2 indexed citations
7.
Nabil-Adam, Asmaa, Mohamed L. Ashour, & Mohamed A. Shreadah. (2023). Modulation of MAPK/NF-κB Pathway and NLRP3 Inflammasome by Secondary Metabolites from Red Algae: A Mechanistic Study. ACS Omega. 8(41). 37971–37990. 12 indexed citations
8.
Shreadah, Mohamed A., et al.. (2022). Application of Printing and Finishing Cotton Fabrics with Natural Dyes; a Review. Egyptian Journal of Chemistry. 0(0). 0–0. 5 indexed citations
9.
Nabil-Adam, Asmaa, et al.. (2021). A review article on nanotechnology in aquaculture sustainability as a novel tool in fish disease control. Aquaculture International. 29(4). 1459–1480. 82 indexed citations
10.
Nabil-Adam, Asmaa & Mohamed A. Shreadah. (2021). Ameliorative role of Ulva extract against heavy metal mixture—induced cardiovascular through oxidative/antioxidant pathways and inflammatory biomarkers. Environmental Science and Pollution Research. 28(21). 27006–27024. 4 indexed citations
11.
Nabil-Adam, Asmaa & Mohamed A. Shreadah. (2020). Red algae natural products for prevention of lipopolysaccharides (LPS)-induced liver and kidney inflammation and injuries. Bioscience Reports. 41(1). 22 indexed citations
12.
Nabil-Adam, Asmaa, et al.. (2020). Various <i>In Vitro</i> Bioactivities of Secondary Metabolites Isolated from the Sponge <i>Hyrtios aff. Erectus</i> from the Red Sea Coast of Egypt. Turkish Journal of Pharmaceutical Sciences. 17(2). 127–135. 9 indexed citations
13.
Nabil-Adam, Asmaa, et al.. (2020). Marine Algae of the Genus Gracilaria as Multi Products Source for Different Biotechnological and Medical Applications. Recent Patents on Biotechnology. 14(3). 203–228. 18 indexed citations
14.
Nabil-Adam, Asmaa & Mohamed A. Shreadah. (2020). Biogenic Silver Nanoparticles Synthesis from New Record Aquatic Bacteria of Nile Tilapia and Evaluation of their Biological Activity. SHILAP Revista de lepidopterología. 14(4). 2491–2511. 2 indexed citations
15.
Nabil-Adam, Asmaa, et al.. (2019). Pesudomance sp. Bacteria Associated with Marine Sponge as a Promising and Sustainable Source of Bioactive Molecules. Current Pharmaceutical Biotechnology. 20(11). 964–984. 10 indexed citations
16.
Shreadah, Mohamed A., et al.. (2018). Phytochemical and pharmacological screening of Sargassium vulgare from Suez Canal, Egypt. Food Science and Biotechnology. 27(4). 963–979. 22 indexed citations
19.
Abdel-Azeem, Ahmed M., et al.. (2013). Pretreatment Hepatoprotective Effect of the Marine Fungus Derived from Sponge on Hepatic Toxicity Induced by Heavy Metals in Rats. BioMed Research International. 2013. 1–15. 23 indexed citations
20.
Nabil-Adam, Asmaa & E. Lederer. (1984). Immunomodulation : New frontiers and advances. Biochimie. 66(7-8). XXVI–XXVI. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026